Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MYC | P01106 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TTR | P02766 | 1/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30700 | 0.98 | GABRA1 (0.44) | GABRA1GABRB2POLBMYCCYP2D6 | |
| SCHEMBL6548552 | 0.98 | GABRA1 (0.44) | GABRA1GABRB2POLBMYCCYP2D6 | |
| SCHEMBL553258 | 0.96 | GABRA1 (0.43) | GABRA1GABRB2POLBMYCCYP2D6 | |
| SCHEMBL10441275 | 0.96 | GABRA1 (0.43) | GABRA1GABRB2POLBMYCCYP2D6 | |
| SCHEMBL27170 | 0.96 | GABRA1 (0.43) | GABRA1GABRB2POLBMYCCYP2D6 | |
| Hydrochloric Acid SCHEMBL3958477 | 0.96 | GABRA1 (0.43) | GABRA1GABRB2POLBMYCCYP2D6 | |
| Potassium SCHEMBL9463470 | 0.96 | GABRA1 (0.43) | GABRA1GABRB2POLBMYCCYP2D6 | |
| Phosphine SCHEMBL4233486 | 0.96 | GABRA1 (0.43) | GABRA1GABRB2POLBMYCCYP2D6 | |
| Phosphine SCHEMBL4233487 | 0.96 | GABRA1 (0.43) | GABRA1GABRB2POLBMYCCYP2D6 | |
| Water SCHEMBL10337655 | 0.96 | GABRA1 (0.43) | GABRA1GABRB2POLBMYCCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9039936-B2 | Thiophene derivative, method for producing same, and polymer of thiophene derivative | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2015-05-26 | — | — | US | disclosed |
| EP-2457909-A1 | THIOPHENE DERIVATIVE, METHOD FOR PRODUCING SAME, AND POLYMER OF THIOPHENE DERIVATIVE | Tokyo Institute of Technology (JP) | 2012-05-30 | — | — | EP | disclosed |
| US-20120119157-A1 | THIOPHENE DERIVATIVE, METHOD FOR PRODUCING SAME, AND POLYMER OF THIOPHENE DERIVATIVE | KURARAY CO., LTD. (JP) | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120119157-A1 | THIOPHENE DERIVATIVE, METHOD FOR PRODUCING SAME, AND POLYMER OF THIOPHENE DERIVATIVE | TST, WEE2, WEE1 | GABRA1 3999/4885GABRB2 2283/4885POLB 3233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.